A chronic, complex disease that can harm a person’s health, obesity is defined by excessive fat deposits. Obesity can affect the health of bones and reproductive organs, and increase the risk of

Heartburn, another name for acid reflux, is a frequent illness in which stomach acid escapes the stomach and re-enters the oesophagus. Heartburn and regurgitation are two symptoms that may result from this

Alzheimer’s disease (AD) is a neurodegenerative disease that causes progressive dementia. There is a theory that insulin resistance in the brain plays a role in AD, and this theory is referred to

Mounjaro is a medication used to treat type 2 diabetes and obesity with people with a BMI of 30 or above. In this blog, we discuss the suitability and requirements needed to

Semaglutide is a drug belonging to the class of medications: Glucagon-like peptide -1 receptor agonists (GLP-1 RA). GLP-1 is a hormone of the gastrointestinal tract which is stimulated upon consumption of food.

The pharmaceutical market now has novel anti-obesity drugs and anti-diabetic medications which may work coherently to improve the health of individuals. Semaglutide, tirzepatide and liraglutide are novel agents which are prescribed to

What is Wegovy? Wegovy is the trade name for injection semaglutide used for weight loss. It has been gaining popularity in the UK over the past year due to its efficacy in

There are many new weight management medications available for people to be prescribed. Each medication has varying effectiveness on the amount of weight a person may lose. However, like any other medication,

Semaglutide is an active component used in the medications – Ozempic, Wegovy and Rybelsus. Rybelsus and Ozempic are medications approved for the treatment of type 2 diabetes and Wegovy is approved for